Acute Pharyngitis, Tonsillitis, and Peritonsillar Abscess

Chapter

Abstract

Most cases of pharyngitis are viral, but distinguishing viral from bacterial infections clinically is difficult. A rapid antigen detection test and/or throat culture is required to distinguish viral pharyngitis from pharyngitis due to group A Streptococcus (GAS), although a clinical scoring system can be helpful in predicting viral cases. Fusobacterium necrophorum, an anaerobe, is not identified on routine throat culture, yet it is a common cause of pharyngitis and peritonsillar abscess in adolescents and young adults. Peritonsillar abscess usually requires surgical drainage by needle aspiration or incision, in addition to antibiotic therapy. This chapter reviews the epidemiology, microbiology, clinical features, differential diagnosis, and treatment of pharyngitis and peritonsillar abscess.

Keywords

Pharyngitis Tonsillitis Peritonsillar abscess Group A Streptococcus Fusobacterium necrophorum EBV HIV Mononucleosis Tonsillectomy 

Notes

Acknowledgments

The authors would like to acknowledge Ramy Elshaboury PharmD., B.C.P.S.-A.Q. I.D. for his review of Table 17.3.

References

  1. 1.
    Lee K. Essential otolaryngology head and neck surgery. 8th ed. New York: McGraw Hill; 2003.Google Scholar
  2. 2.
    Proud D, Reynolds CJ, Lacapra S, Kagey-Sobotka A, Lichtenstein LM, Naclerio RM. Nasal provocation with bradykinin induces symptoms of rhinitis and a sore throat. Am Rev Respir Dis. 1988;137(3):613–6.CrossRefGoogle Scholar
  3. 3.
    Rees G, Eccles R. Sore throat following nasal and oropharyngeal bradykinin challenge. Acta Otolaryngol. 1994;114:311–4.CrossRefGoogle Scholar
  4. 4.
    Eccles R. Understanding the symptoms of the common cold and influenza. Lancet Infect Dis. 2005;5(11):718–25.CrossRefGoogle Scholar
  5. 5.
    Schappert SM, Burt CW. Ambulatory care visits to physician offices, hospital outpatient departments, and emergency departments: United States, 2001–02. Vital Health Stat. 2006;13(159):1–66.Google Scholar
  6. 6.
    André M, Odenholt I, Schwan A, Axelsson I, Eriksson M, Hoffman M, et al. Upper respiratory tract infections in general practice: diagnosis, antibiotic prescribing, duration of symptoms and use of diagnostic tests. Scand J Infect Dis. 2002;34(12):880–6.CrossRefGoogle Scholar
  7. 7.
    Fleming-Dutra KE, Hersh AL, Shapiro DJ, Bartoces M, Enns EA, File TM, et al. Prevalence of inappropriate antibiotic prescriptions among US ambulatory care visits, 2010–2011. JAMA. 2016;315(17):1864.CrossRefGoogle Scholar
  8. 8.
    Huovinen P, Lahtonen R, Ziegler T, Meurman O, Hakkarainen K, Miettinen A, et al. Pharyngitis in adults: the presence and coexistence of viruses and bacterial organisms. Ann Intern Med. 1989;110(8):612–6.CrossRefGoogle Scholar
  9. 9.
    Esposito S, Blasi F, Bosis S, Droghetti R, Faelli N, Lastrico A, et al. Aetiology of acute pharyngitis: the role of atypical bacteria. J Med Microbiol. 2004;53(7):645–51.CrossRefGoogle Scholar
  10. 10.
    Louie JK, Hacker JK, Gonzales R, Mark J, Maselli JH, Yagi S, et al. Characterization of viral agents causing acute respiratory infection in a San Francisco University Medical Center Clinic during the influenza season. Clin Infect Dis. 2005;41(6):822–8.CrossRefGoogle Scholar
  11. 11.
    Dominguez O, Rojo P, De Las Heras S, Folgueria D, Contreras J. Clinical presentation and characteristics of pharyngeal adenovirus infections. Pediatr Infect Dis J. 2005;24(8):731–45.CrossRefGoogle Scholar
  12. 12.
    McMillan NS, Martin SA, Sobsey MD, Wait DA, Meriweather RA, MacCormack JN. Outbreak of pharyngoconjunctival fever at a summer camp-North Carolina, 1991. MMWR. 1992;41(19):343–4.Google Scholar
  13. 13.
    Österback R, Vuorinen T, Linna M, Susi P, Hyypiä T, Waris M. Coxsackievirus A6 and hand, foot, and mouth disease, Finland. Emerg Infect Dis. 2009;15(9):1485–8.CrossRefGoogle Scholar
  14. 14.
    Downing C, Ramirez-Fort MK, Doan HQ, Benoist F, Oberste MS, Khan F, et al. Coxsackievirus A6 associated hand, foot and mouth disease in adults: clinical presentation and review of the literature. J Clin Virol. 2014;60(4):381–6.CrossRefGoogle Scholar
  15. 15.
    Case #04054: a child with skin lesions (Internet) Partners infectious disease images. http://www.idimages.org/idreview/case/caseid=462.
  16. 16.
    Bruch JM, Treister NS. Clinical oral medicine and pathology. 2nd ed. New York: Springer; 2017.CrossRefGoogle Scholar
  17. 17.
    Ebell MH, Call M, Shinholser J, Gardner J. Does this patient have infectious mononucleosis? JAMA. 2016;315(14):1502.CrossRefGoogle Scholar
  18. 18.
    Aronson M, Komaroff A, Pass T, Ervin C, WT B. Heterophil antibody in adults with sore throat. Ann Intern Med. 1982;96:505–8.CrossRefGoogle Scholar
  19. 19.
    Hurt C, Tammaro D. Diagnostic evaluation of mononucleosis-like illnesses. Am J Med. 2007;120(10):1–8.CrossRefGoogle Scholar
  20. 20.
    Chovel-Sella A, Ben Tov A, Lahav E, et al. Incidence of rash after amoxicillin treatment in children with infectious mononucleosis. Pediatrics. 2013;131(5):e1424–7.CrossRefGoogle Scholar
  21. 21.
    McCloskey GL, Massa MC. Cephalexin rash in infectious mononucleosis. Cutis. 1997;59:251–4.PubMedGoogle Scholar
  22. 22.
    Banerjee I, Mondal S, Sen S, et al. Azithromycin-induced rash in a patient of infectious mononucleosis – a case report with review of literature. J Clin Diagn Res. 2014;8(8):HD01–2.PubMedPubMedCentralGoogle Scholar
  23. 23.
    Paily R. Quinolone drug rash in a patient with infectious mononucleosis. J Dermatol. 2000;27(6):405–6.CrossRefGoogle Scholar
  24. 24.
    Ónodi-Nagy K, Kinyo A, Meszes A, et al. Amoxicillin rash in patients with infectious mononucleosis: evidence of true drug sensitization. Allergy, Asthma Clin Immunol. 2015;11:1.CrossRefGoogle Scholar
  25. 25.
    Linderholm M, Boman J, Juto P, Linde A. Comparative evaluation of nine kits for rapid diagnosis of infectious mononucleosis and Epstein-Barr virus-specific serology. J Clin Microbiol. 1994;32(1):259–61.PubMedPubMedCentralGoogle Scholar
  26. 26.
    Bruu AL, Hjetland R, Holter E, Mortensen L, Natås O, Petterson W, et al. Evaluation of 12 commercial tests for detection of Epstein-Barr virus-specific and heterophile antibodies. Clin Diagn Lab Immunol. 2000;7(3):451–6.PubMedPubMedCentralGoogle Scholar
  27. 27.
    Klutts JS, Wu AHB, Smith A, Yen-Lieberman B, Gronowski AM. Diagnostic performance of a new automated heterophile antibody test in adults and children. Diagn Microbiol Infect Dis. 2008;61(3):351–3.CrossRefGoogle Scholar
  28. 28.
    Centers for Disease Control and Prevention. https://www.cdc.gov/epstein-barr/laboratory-testing.html. Accessed 10 May 2017.
  29. 29.
    Rezk E, Nofal YH, Hamseh A, Aboujaib MF, AlKheder MA, Al Hammad MF. Steroids for symptoms control in infectious mononucleosis. Cochrane Database Syst Rev. 2015;11:1–28.Google Scholar
  30. 30.
    Hecht FM, Busch MP, Rawal B, Webb M, Rosenberg E, Swanson M, et al. Use of laboratory tests and clinical symptoms for identification of primary HIV infection. AIDS. 2002;16(8):1119–29.CrossRefGoogle Scholar
  31. 31.
    Delaney KP, Hanson DL, Masciotra S, Ethridge SF, Wesolowski L, Owen SM. Time until emergence of HIV test reactivity following infection with HIV-1: implications for interpreting test results and retesting after exposure. Clin Infect Dis. 2016;64(1):53–9.CrossRefGoogle Scholar
  32. 32.
    McMillan JA, Weiner LB, Higgins AM, Lamparella VJ. Pharyngitis associated with herpes simplex virus in college students. Pediatr Infect Dis J. 1993;12:280–4.CrossRefGoogle Scholar
  33. 33.
    Rosain J, Froissart A, Estrangin E, Rozenberg F. Severe acute pharyngotonsillitis due to herpes simplex virus type 2 in a young woman. J Clin Virol. 2015;63:63–5.CrossRefGoogle Scholar
  34. 34.
    Shulman ST, Bisno AL, Clegg HW, Gerber MA, Kaplan EL, Lee G, et al. Clinical practice guideline for the diagnosis and management of group a streptococcal pharyngitis: 2012 update by the infectious diseases society of America. Clin Infect Dis. 2012;55(10):86–102.CrossRefGoogle Scholar
  35. 35.
    Bisno AL. Acute pharyngitis. N Engl J Med. 2001;344(3):205–11.CrossRefGoogle Scholar
  36. 36.
    Ebell MH. Does this patient have strep throat? J Am Med Assoc. 2000;284(22):2912–8.CrossRefGoogle Scholar
  37. 37.
    Weinberg, AN. Case #06033: a patient with fever, pharyngitis and a rash (Internet). Partners infectious disease images. http://www.idimages.org/idreview/case/caseid=436.
  38. 38.
    Centor R, Witherspoon J, Dalton H, Brody C, Link K. The diagnosis of strep throat in adults in the emergency room. Med Decis Mak. 1981;1(3):239–46.CrossRefGoogle Scholar
  39. 39.
    Fine AM, Nizet V, Mandl KD. Large-scale validation of the Centor and McIsaac Scores to PREDICT GROUP A Streptococcal pharyngitis. Arch Intern Med. 2013;172(11):847–52.Google Scholar
  40. 40.
    Mclsaac WJ, White D, Tannenbaum D, Low DE. A clinical score to reduce unnecessary antibiotic use in patients with sore throat. CMAJ. 1998;158(1):75–83.Google Scholar
  41. 41.
    Centor RM, Atkinson TP, Ratliff AE, Xiao L, Crabb DM, Estrada CA, et al. The clinical presentation of Fusobacterium-positive and streptococcal-positive pharyngitis in a university health clinic: a cross-sectional study. Ann Intern Med. 2015;162(4):241–7.CrossRefGoogle Scholar
  42. 42.
    Windfuhr JP, Toepfner N, Steffen G, Waldfahrer F, Berner R. Clinical practice guideline: tonsillitis I. Diagnostics and nonsurgical management. Eur Arch Oto-Rhino-Laryngology, 2016;273(4):973–87.CrossRefGoogle Scholar
  43. 43.
    Olzowy B, Kresken M, Havel M, Hafner D. Antimicrobial susceptibility of bacterial isolates from patients presenting with ear , nose and throat ( ENT ) infections in the German community healthcare setting. Eur J Clin Microbiol Infect Dis. 2017.  https://doi.org/10.1007/s10096-017-2985-9.
  44. 44.
    Turner JC, Hayden FG, Lobo MC, Ramirez CE, Murren D. Epidemiologic evidence for Lancefield group C beta-hemolytic streptococci as a cause of exudative pharyngitis in college students. J Clin Microbiol. 1997;35(1):1–4.PubMedPubMedCentralGoogle Scholar
  45. 45.
    Meier FA, Centor RM, Graham L, Dalton HP. Clinical and microbiological evidence for endemic pharyngitis among adults due to group C streptococci. Arch Intern Med. 1990;150(4):825–9.CrossRefGoogle Scholar
  46. 46.
    Gerber MA, Randolph MF, Martin NJ, Rizkallah MF, Cleary PP, Kaplan EL, et al. Community-wide outbreak of group G Streptococcal pharyngitis. Pediatrics. 1991;87(5):598–603.PubMedGoogle Scholar
  47. 47.
    Hill HR, Caldwell GG, Zimmerman RA. Epidemic of pharyngitis due to streptococci of lancefield group G. Lancet. 1969;2:371–4.CrossRefGoogle Scholar
  48. 48.
    Huggan PJ, Murdoch DR. Fusobacterial infections: clinical spectrum and incidence of invasive disease. J Infect. 2008;57(4):283–9.CrossRefGoogle Scholar
  49. 49.
    Batty A, Wren M. Prevalence of Fusobacterium necrophorum and other upper respiratory tract pathogens isolated from throat swabs. Br J Biomed Sci. 2005;62(2):66–70.CrossRefGoogle Scholar
  50. 50.
    Eaton C, Swindells J. The significance and epidemiology of Fusobacterium necrophorum in sore throats. J Infect. 2014;69(2):194–6.CrossRefGoogle Scholar
  51. 51.
    Kuppalli K, Livorsi D, Talati NJ, Osborn M. Lemierre’s syndrome due to Fusobacterium necrophorum. Lancet Infect Dis. 2012;12(10):808–15.CrossRefGoogle Scholar
  52. 52.
    Centor RM. Expand the pharyngitis paradigm for adolescents and young adults. Ann Intern Med. 2009;151(11):812–5.CrossRefGoogle Scholar
  53. 53.
    Mackenzie A, Fuite LA, Chan FTH, King J, Allen U, MacDonald N, et al. Incidence and pathogenicity of Arcanobacterium haemolyticum during a 2-year study in Ottawa. Clin Infect Dis. 1995;21(1):177–81.CrossRefGoogle Scholar
  54. 54.
    Gaston DA, Zurowski SM. Arcanobacterium haemolyticum pharyngitis and exanthem. Arch Dermatol. 1996;132:61–4.CrossRefGoogle Scholar
  55. 55.
    American Academy of Pediatrics. Arcanobacterium haemolyticum infections. In: Pickering LK, Baker CJ, Kimberlin DW, Long SS, editors. Red book: 2012 report of the committee on infectious diseases. Elk Grove Village, IL: American Academy of Pediatrics; 2012. p. 238–9.Google Scholar
  56. 56.
    Almuzara MN, de Mier C, Barberis CM, Mattera J, Famiglietti A, Vay C. Arcanobacterium hemolyticum: identification and susceptibility to nine antimicrobial agents. Clin Microbiol Infect. 2002;8(12):828–9.CrossRefGoogle Scholar
  57. 57.
    Peeling R. Laboratory diagnosis of Chlamydia pneumoniae infections. Can J Infect Dis. 1995;6(4):198–202.CrossRefGoogle Scholar
  58. 58.
    Oda K, Yano H, Okitsu N, Chiba T, Hara Y, Kudo T, et al. Detection of Chlamydia trachomatis or Neisseria gonorrhoeae in otorhinolaryngology patients with pharyngeal symptoms. Sex Transm Infect. 2014;90(2):99.CrossRefGoogle Scholar
  59. 59.
    Dudareva-Vizule S, Haar K, Sailer A, Wisplinghoff H, Wisplinghoff F, Marcus U. Prevalence of pharyngeal and rectal Chlamydia trachomatis and Neisseria gonorrhoeae infections among men who have sex with men in Germany. Sex Transm Infect. 2014;90(1):46–51.CrossRefGoogle Scholar
  60. 60.
    Centers for Disease Control and Prevention. http://www.cdc.gov/std/tg2015/gonorrhea.htm. Accessed May 2017.
  61. 61.
    Papp J, Schacter J, Gaydos C, Van Der Pol B. Recommendations for the laboratory-based detection of Chlamydia trachomatis and Neisseria gonorrhea-2014. MMWR. 2014;63:1–19.PubMedCentralGoogle Scholar
  62. 62.
    Workowski KA, Bolan GA. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep. 2015;64(3):55–68.Google Scholar
  63. 63.
    Burton MJ, Glasziou PP, Chong LY, Venekamp RP. Tonsillectomy or adenotonsillectomy versus non-surgical treatment for chronic/recurrent acute tonsillitis. Cochrane Collab. 2014;11:1–84.Google Scholar
  64. 64.
    Windfuhr JP, Toepfner N, Steffen G, Waldfahrer F, Berner R. Clinical practice guideline: tonsillitis II. Surgical management. Eur Arch Oto-Rhino-Laryngology. 2016;273(4):989–1009.CrossRefGoogle Scholar
  65. 65.
    Baugh RF, Archer SM, Mitchell RB, et al. Clinical practice guideline: tonsillectomy in children. Otolaryngol Head Neck Surg. 2011 Jan;144(1 Suppl):S1–30.CrossRefGoogle Scholar
  66. 66.
    Mazur E, Czerwińska E, Korona-Głowniak I, Grochowalska A, Kozioł-Montewka M. Epidemiology, clinical history and microbiology of peritonsillar abscess. Eur J Clin Microbiol Infect Dis. 2015;34(3):549–54.CrossRefGoogle Scholar
  67. 67.
    Powell J, Wilson JA. An evidence-based review of peritonsillar abscess. Clin Otolaryngol. 2012;37(2):136–45.CrossRefGoogle Scholar
  68. 68.
    Ehlers Klug T, Rusan M, Fuursted K, Ovesen T. Fusobacterium necrophorum: most prevalent pathogen in peritonsillar abscess in Denmark. Clin Infect Dis. 2009;49(10):1467–72.CrossRefGoogle Scholar
  69. 69.
    Souza DLS, Cabrera D, Gilani WI, Campbell RL, Carlson ML, Lohse CM, et al. Comparison of medical versus surgical management of peritonsillar abscess: a retrospective observational study. Laryngoscope. 2016;126(7):1529–34.CrossRefGoogle Scholar
  70. 70.
    Johnson RF, Stewart MG, Wright CC. An evidence-based review of the treatment of peritonsillar abscess. Otolaryngol Head Neck Surg. 2003;128(3):332–43.CrossRefGoogle Scholar
  71. 71.
    Klug TE. Incidence and microbiology of peritonsillar abscess: the influence of season, age, and gender. Eur J Clin Microbiol Infect Dis. 2014;33(7):1163–7.CrossRefGoogle Scholar
  72. 72.
    Klug TE, Rusan M, Clemmensen KKB, Fuursted K, Ovesen T. Smoking promotes peritonsillar abscess. Eur Arch Otorhinolaryngol. 2013;270:1–5.CrossRefGoogle Scholar
  73. 73.
    Lee YJ, Jeong YM, Lee HS, Hwang SH. The efficacy of corticosteroids in the treatment of peritonsillar abscess: a meta-analysis. Clin Exp Otorhinolaryngol. 2016;9(2):89–97.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Division of Infectious Diseases, Department of MedicineMassachusetts General Hospital, Harvard Medical SchoolBostonUSA
  2. 2.Massachusetts Eye and Ear InfirmaryBostonUSA

Personalised recommendations